Guidelines for the Diagnosis and Management of Neuropathic Pain: Consensus of a Group of Latin American Experts

REFERENCES

• Guevara-López U, Covarrubias-Gómez A, García-Ramos G. Hernández-Jiménez S; Grupo de Consen- so para el Manejo del Dolor neuropático. [Practice guidelines for neuropathic pain management.]. Rev Invest Clin 2006; 58: 126–138
   Google Scholar
• Ruiz F, Carrasco M L. El dolor neuropático en la consulta médica en América Latina: resultado de una encuesta en cinco países. Rev Iberoamerican Dolor 2008, www.revistaiberoamericanadedolor.org aceptado para su publicación
   Google Scholar
• Dworkin R H, Backonja M, Rowbotham M C, et al. Advances in neuropathic pain. Arch Neurol 2003; 60: 1524–1534
   PubMed Web of Science ®Google Scholar
• Moulin D E, Clark A J, Gilron I, et al. Pharmacologi-cal management of chronic neuropathic pain-consen- sus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007; 12: 13–21
   PubMed Web of Science ®Google Scholar
• Finnerup N B, Otto M, Jensen T S, Sindrup S H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289–305
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Haanpää M, Hansson P, Jensen T S, Nurmikko T, Sampaio C, Sindrup S, Wiffen P; EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–1169
   PubMed Web of Science ®Google Scholar
• Dworkin R H, O'Connor A B, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237–251
   PubMed Web of Science ®Google Scholar
• Aguilera J, Arizaga E, Carpio A, et al. Guías de práctica clínica del dolor neuropático (II). Rev Neurol 2005; 1–15(40)303–316
   Google Scholar
• Cepeda M S, Farrar J T. Economic evaluation of oral treatments for neuropathic pain. J Pain 2006; 7: 119–128
   PubMed Web of Science ®Google Scholar
• Asociación Venezolana para el Estudio del Dolor (AVED). Consenso venezolano sobre dolor neuropático. AVED 2008; 200
   Google Scholar
• Treede R D, Jensen T S, Campbell J N, Cruccu G, Dostrovsky J O, Griffin J W, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630–1635
   PubMed Web of Science ®Google Scholar
• Gómez-Barrios J V. Dolor neuropático localizado: del origen al diagnóstico. Rev Iberoamerican Dolor 2007; 2: 18–23, www.revistaiberoamericanadedolor.org
   Google Scholar
• Hernández J J, Moreno C. Dolor neuropático, la gran incógnita. Dolor neuropático: fisiopatología, diagnóstico y manejo, J J Hernández, C Moreno. Editorial Universidad del Rosario, Colombia 2006; 20–31
   Google Scholar
• Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004; 108: 248–257
   PubMed Web of Science ®Google Scholar
• Alonso J, et al. Versión española del SF-36 Health Survey (Cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barcelona) 1995; 104: 771–776
   PubMed Web of Science ®Google Scholar
• Ruiz T E. Estandarización de la escala de Beck para medir trastornos depresivos en mujeres menopáusicas de la población mexicana que acude al Centro Nacional de Rehabilitación-Ortopedia. Rev Mex Med Física Rehab 2001; 13: 9–13
   Google Scholar
• Dennis P, Carmody D P, Lega L. Características psi-cométricas del Inventario de Depresión de Beck-II. Versión en Español, http://www.umdnj.edu/iscdweb/psicologiaconductual2004.pdf
   Google Scholar
• Dal-Ré R, Budia A. L, Ibarra N, Bobes J, Bulbena A, Ballesteros J. Evaluación psicométrica comparativa de las versiones en español de 6, 17 y 21 ítems de la Escala de valoración de Hamilton para la evaluación de la depresión. Med Clin 2003; 120: 693–700
   Google Scholar
• Emerging Strategies for the Treatment of Neuropathic Pain, J N Campbell, A I Basbaum, A Dray, R Dubner, R H Dworkin, C N Sang. IASP Press, Seattle 2006
   Google Scholar
• Ziegler D, Nowak H, Kempler P, Vargha P, Low P A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21: 114–121
   PubMed Web of Science ®Google Scholar
• Tang J, Wingerchuk D M, Crum B A, Rubin D I, Demaerschalk B M. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist 2007; 13: 164–167
   PubMed Web of Science ®Google Scholar
• Pain & Policy Studies Group. University of Wisconsin. WHO Collaborating Center, See: http://www.painpolicy.wisc.edu
   Google Scholar
• Codd E E, Martinez R P, Molino L, Rogers K E, Stone D J, Tallarida R J. Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia. Pain Feb, 2008; 134(3)254–262, doi:10.1016/j. pain.2007.04.019
   PubMedGoogle Scholar
• Gilron I, Bailey J M, Tu D, Holden R R, Weaver D F, Houlden R L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 1324–1334, (352)
   Google Scholar
• Gilron I, Max M B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother Nov, 2005; 5(6)823–830
   PubMedGoogle Scholar
• Zepeda-Vázquez T C, Hernández-Santos J R, Tenopala-Villegas S. Manejo del dolor neuropático en el paciente diabético con tramadol vía oral comparado con la administración del mismo asociado a la amitriptilina y gabapentina. Rev Mex Anest 2001; 24: 84–87
   Google Scholar
• Smith K, Roberts M. Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain 2007; 8: 396–404
   PubMed Web of Science ®Google Scholar
• Goldstein D J, Lu Y, Detke M J, Lee T C, Lyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109–118
   PubMed Web of Science ®Google Scholar
• Weinberg J M. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol 2007; 57(6 Suppl)S130–S135
   PubMed Web of Science ®Google Scholar
• Longás J, Girón J A, Martínez-Ubieto J, et al. Lidocaína endovenosa como coadyuvante en el tratamiento inicial de la neuralgia postherpética. Bases fisiopatológicas del uso de anestésicos locales en el tratamiento del dolor neuropático. Rev Soc Esp Dolor 2005; 12: 485–490
   Google Scholar
• Campbell J N, Meyer J E. Mechanisms of neuropathic pain. Neuron 2006; 52: 77–92
   PubMed Web of Science ®Google Scholar
• Prada D M, Moreno C, Carreño J N. Neuropatía diabética dolorosa. Dolor neuropático: fisiopatología, diagnóstico y manejo, J J Hernández, C Moreno. Universidad del Rosario, Colombia 2006; 84–97
   Google Scholar
• Baron R. Diagnosis and treatment of neuropathic pain. Dtsch Arztebl 2006; 103: 2720–2730
   Google Scholar
• Baron R, Binder A, Koroschetz J, Serpell M G, Steigerwald I. I. Efficacy and tolerability of a 5% lidocaine-medicated plaster vs. pregabalin in patients with post-herpetic neuralgia and painful diabetic polyneuropathy: results from an interim analysis of a randomized, controlled trial. 2008, PW 228. Abstract. World Congress on Pain. Glasgow. August 17–22
   Google Scholar
• Hans G, Baron R, Binder A. A, Boesl I. Long-term efficacy and tolerability of a 5% lidocaine-medica-ted plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. 2008, Abstract. PW 226. World Congress on Pain. Glasgow. August 17–22
   Google Scholar
• De Leon-Casasola O. Multimodal approaches to the management of neuropathic pain: the role of topical analgesia. J Pain Sym Manag 2007; 33: 356–364
   PubMed Web of Science ®Google Scholar
• Kang L, Jun H W. Formulation and efficacy studies of new topical anesthetic creams. Drug Dev Ind Pharm 2003; 29: 505–512
   PubMed Web of Science ®Google Scholar
• Lynch M E, Clark A J, Sawynok J. A pilot study exa-mining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003; 19: 323–328
   PubMed Web of Science ®Google Scholar
• Lynch M E, Clark A J, Sawynok J, Sullivan M J. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 2005; 6: 644–649
   PubMed Web of Science ®Google Scholar
• Lynch M E, Clark A J, Sawynok J, Sullivan M J. To-pical 2% amitriptyline and 1% ketamine in neuro-pathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 2005; 103: 140–146
   PubMed Web of Science ®Google Scholar
• Rodríguez M J. Buprenorfina transdérmica en el tratamiento del dolor neuropático. Rev Soc Esp Dolor 2004; 11(Suppl.V)11–21
   Google Scholar
• Freynhagen R, Baron R, Ulrich Gockel U, Tölle T. PAINDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911–1920
   PubMed Web of Science ®Google Scholar
• Rabah E. Dolor crónico como resultado adverso de la cirugía. I Parte: amputación de extremidades, cirugía torácica y cirugía de la mama. Rev Iberoamericana del Dolor 2007; 2: 16–22
   Google Scholar
• Rabah E. Dolor crónico como resultado adverso de la cirugía. II Parte: colecistectomía y hernioplastía inguinal. Rev Iberoamericana del Dolor 2007; 3: 20–25
   Google Scholar
• Bolívar M, Hernández L, Navas T, Parada L. Síndrome doloroso regional complejo (SDRC). Consenso venezolano sobre dolor neuropático. Asociación Venezolana para el Estudio del Dolor (AVED). 2008; 127–156
   Google Scholar
• Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Investig 2007; 27: 75–83
   PubMed Web of Science ®Google Scholar